Sales & Marketing Business strategy and forecasting team: Ally or adversary? It’s 2023 and pharma is moving ahead and leaving behind the COVID-19 aftermath.
Market Access Sponsored The changing face of pharmaceutical launches The industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues to evolve, with significant ramifications for new pharmaceutical launches.<
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
